Abstract
Candidate markers for endothelial cell, lymphocyte and fibroblast function in systemic sclerosis have been reviewed. Autoantibody measurement and general inflammatory markers were considered the minimum requirements, with other markers needing further evaluation.
Original language | English |
---|---|
Pages (from-to) | S32-38 |
Journal | Clinical and Experimental Rheumatology |
Volume | 21 |
Issue number | 3 Suppl 29 |
Publication status | Published - 2003 |